Close Menu

NEW YORK — 908 Devices, a developer of miniature mass spectrometers, last week filed with the US Securities and Exchange Commission to go public on the Nasdaq market.

The Boston, Massachusetts-based company did not specify the number of shares it plans to offer or give a price range for the proposed initial public offering. Cowen and SVB Leerink will act as lead book-running managers for the proposed offering.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.